\
&
Contact us
\
&
Contact us
This was 5 years ago
LocationOnline
The FET BRIEFING - Bridging the FET Innovation Gap project is a Coordination and Support Action (CSA) that received funding under the Horizon 2020 call FETOPEN-02-2018.
“BRIEFING leverages different ways of exploiting FET research by supporting researchers in their innovation exploration and fostering the connection between the worlds of researchers and different business stakeholder groups.
The BRIEFING portfolio comprises various trainings services for researchers and to-be entrepreneurs from FET Open projects ranging from research communication trainings to innovation opportunity workshops, business trainings as well as matchmaking with industry.”
For Future and Emerging Technologies (FET)/European Innovation Council (EIC) Pathfinder projects a webinar on Innovation and IP Strategy - focus on shared IP in joint research projects - is organized. “The Webinar provides an introduction to the most commonly used IP protection mechanisms and how to use Intellectual Property in a strategic context. In particular, the IP Management approach within the Horizon 2020 framework is discussed as an example for IP in joint research projects.”
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
